ES498756A0 - Un metodo de produccion de una composicion farmaceutica paraadministracion rectal - Google Patents

Un metodo de produccion de una composicion farmaceutica paraadministracion rectal

Info

Publication number
ES498756A0
ES498756A0 ES498756A ES498756A ES498756A0 ES 498756 A0 ES498756 A0 ES 498756A0 ES 498756 A ES498756 A ES 498756A ES 498756 A ES498756 A ES 498756A ES 498756 A0 ES498756 A0 ES 498756A0
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
production method
rectal administration
rectal
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES498756A
Other languages
English (en)
Spanish (es)
Other versions
ES8204597A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ES8204597A1 publication Critical patent/ES8204597A1/es
Publication of ES498756A0 publication Critical patent/ES498756A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
ES498756A 1980-01-25 1981-01-23 Un metodo de produccion de una composicion farmaceutica paraadministracion rectal Granted ES498756A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP803280A JPS56104813A (en) 1980-01-25 1980-01-25 Composition for rectal infusion containing compound having beta-lactam ring

Publications (2)

Publication Number Publication Date
ES8204597A1 ES8204597A1 (es) 1982-05-01
ES498756A0 true ES498756A0 (es) 1982-05-01

Family

ID=11681987

Family Applications (1)

Application Number Title Priority Date Filing Date
ES498756A Granted ES498756A0 (es) 1980-01-25 1981-01-23 Un metodo de produccion de una composicion farmaceutica paraadministracion rectal

Country Status (8)

Country Link
EP (1) EP0033241A3 (enExample)
JP (1) JPS56104813A (enExample)
AR (1) AR224562A1 (enExample)
CA (1) CA1157377A (enExample)
DK (1) DK31681A (enExample)
ES (1) ES498756A0 (enExample)
GR (1) GR73125B (enExample)
PT (1) PT72391B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03235850A (ja) * 1990-02-13 1991-10-21 Nishimatsu Kensetsu Kk 建築構造物の分割開閉型外殻構造
JPH05202643A (ja) * 1992-01-23 1993-08-10 Ohbayashi Corp 膜屋根構造
JP2005312377A (ja) * 2004-04-30 2005-11-10 Asahi Kasei Corp 細胞膜に材料が結合した細胞
JP2005312376A (ja) * 2004-04-30 2005-11-10 Asahi Kasei Corp 細胞表面消化度検出用化合物
CN117045586A (zh) * 2023-09-05 2023-11-14 苏州盛达药业有限公司 一种头孢克洛组合物栓剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4930519A (enExample) * 1972-07-14 1974-03-19
JPS4950119A (enExample) * 1972-09-21 1974-05-15
CH615098A5 (en) * 1974-07-04 1980-01-15 Sandoz Ag Pharmaceutical formulation for enteral administration with good absorption of active ingredient
DE2528257C2 (de) * 1974-07-04 1986-02-13 Sandoz-Patent-GmbH, 7850 Lörrach Neue galenische Zubereitung
DE2619756A1 (de) * 1975-05-10 1976-11-18 Yamanouchi Pharma Co Ltd Pharmazeutische zubereitungen von penicillinverbindungen zum rektalen gebrauch

Also Published As

Publication number Publication date
DK31681A (da) 1981-07-26
ES8204597A1 (es) 1982-05-01
CA1157377A (en) 1983-11-22
PT72391A (en) 1981-02-01
PT72391B (en) 1981-12-21
EP0033241A3 (en) 1982-04-21
GR73125B (enExample) 1984-02-06
JPS56104813A (en) 1981-08-20
AR224562A1 (es) 1981-12-15
EP0033241A2 (en) 1981-08-05
JPS6348847B2 (enExample) 1988-09-30

Similar Documents

Publication Publication Date Title
ES503132A0 (es) Un procedimiento de preparacion de una composicion farmaceu-tica de un esteroide
ES499224A0 (es) Un procedimiento de produccion de derivados de fenetilamina sulfamoil-sustituidos
AR229612A1 (es) Metodo de licuar una carga de vidrio
ES518800A0 (es) Un metodo de producir derivados de tiazolidina.
ES497559A0 (es) Metodo de fabricacion de una lampara de descarga
ES513827A0 (es) Un metodo de produccion de un derivado de tilosina.
RO81943A (ro) Procedeu de preparare a unor derivati de piridoxina
IT1068345B (it) Metodo per la produzione di una gabbia per rulli
ES519771A0 (es) Un metodo de producir una preparacion farmaceutica que contiene un derivado de sulfonil urea.
ES508490A0 (es) "un metodo de produccion de derivados de tiazolidina".
ES540907A0 (es) Un metodo de producir una composicion farmaceutica estabili-zada
ES496884A0 (es) Metodo de fabricacion de una lampara de descarga
ES499350A0 (es) Un metodo de preparacion de derivados de imidazolidinonas
PT73929B (en) Process for the preparation of 3-aminopropoxyphenyl derivatives having a pharmaceutical effect
ES525656A0 (es) Un metodo de preparar profarmacos de pilocarpina
ES504927A0 (es) Un proceso para la preparacion de derivados de n-alquilimi- dazoles sustituidos
ES503801A0 (es) Un metodo de fabricacion de una pelicula orientada biaxial- mente
CS516179A2 (en) Method of pharmaceutical production for rectal dosage
RO81927A (ro) Procedeu pentru prepararea unor 5-dihidro0ifenoxi-tetrazolil
ES525421A0 (es) Un metodo de produccion de circonio
FR2332324A1 (fr) Procede pour la preparation de nocardicine a
RO83972A (ro) Procedeu de preparare a derivatilor de oxazafosfarine
ES534261A0 (es) Un metodo de produccion de una composicion de aclarrubicina o hidrocloruro de aclarrubicina
ES522904A0 (es) Un metodo para obtener una preparacion farmaceutica que contiene un derivado de 16 beta-etil-17 beta-hidroxi-estrano.
ES544724A0 (es) Un procedimiento de produccion de una cefalosporina